AIRE expression controls the peripheral selection of autoreactive B cells J Sng, B Ayoglu, JW Chen, JN Schickel, EMN Ferre, S Glauzy, ... Science immunology 4 (34), eaav6778, 2019 | 77 | 2019 |
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production E Cotzomi, P Stathopoulos, CS Lee, AM Ritchie, JN Soltys, FR Delmotte, ... Brain 142 (6), 1598-1615, 2019 | 72 | 2019 |
Emerging stem cell therapies: treatment, safety, and biology J Sng, T Lufkin Stem Cells International 2012, 2012 | 57 | 2012 |
Antigen-mediated regulation in monoclonal gammopathies and myeloma S Nair, J Sng, CS Boddupalli, A Seckinger, M Chesi, M Fulciniti, L Zhang, ... JCI insight 3 (8), 2018 | 50 | 2018 |
Brief report: defective early B cell tolerance checkpoints in Sjögren's syndrome patients S Glauzy, J Sng, JM Bannock, JE Gottenberg, AS Korganow, P Cacoub, ... Arthritis & Rheumatology 69 (11), 2203-2208, 2017 | 45 | 2017 |
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ... Nature communications 10 (1), 2484, 2019 | 37 | 2019 |
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs M Thura, JXE Sng, KH Ang, J Li, A Gupta, JM Hong, CW Hong, Q Zeng Bioscience reports 41 (9), BSR20211491, 2021 | 34 | 2021 |
In vivo genome-wide analysis of multiple tissues identifies gene regulatory networks, novel functions and downstream regulatory genes for Bapx1 and its co-regulation with … S Chatterjee, V Sivakamasundari, SP Yap, P Kraus, V Kumar, X Xing, ... BMC genomics 15, 1-18, 2014 | 19 | 2014 |
Positive and negative selection shape the human naive B cell repertoire JW Chen, JN Schickel, N Tsakiris, J Sng, F Arbogast, D Bouis, D Parisi, ... The Journal of clinical investigation 132 (2), 2022 | 15 | 2022 |
Filling the silent void: genetic therapies for hearing impairment J Sng, T Lufkin Genetics research international 2012, 2012 | 7 | 2012 |
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ... Nature Communications 12, 2021 | 1 | 2021 |
Advances in Stem Cell Therapies T Lufkin, J Sng Pluripotent Stem Cells, 2013 | 1 | 2013 |
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019) M Thura, AQ Al-Aidaroos, A Gupta, CE Chee, SC Lee, KM Hui, J Li, ... NATURE PORTFOLIO, 2021 | | 2021 |